Andrea Difabio's Net Worth
$695 Thousand
Who is Andrea Difabio?
Andrea Difabio does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Bioverativ Inc., and Xenon Pharmaceuticals Inc..
SEC CIK
Andrea Difabio's CIK is 0001692506
Past Insider Trading and Trends
2017 was Andrea Difabio's most active year for acquiring shares with 8 total transactions. Andrea Difabio's most active month to acquire stocks was the month of January. 2018 was Andrea Difabio's most active year for disposing of shares, totalling 10 transactions. Andrea Difabio's most active month to dispose stocks was the month of January. 2022 saw Andrea Difabio paying a total of $0.00 for 135,000 shares, this is the most they've acquired in one year. In 2018 Andrea Difabio cashed out on 196,904.203 shares for a total of $423,392.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Bioverativ Inc. No price found
EVP, Chief Legal OfficerAndrea Difabio used to own units in Common Stock but no longer holds any shares there.acquired a total of 38,763 shares in Bioverativ Inc., Andrea also disposed a total of 40,467.203 shares of Bioverativ Inc. equalling to $695,027.62.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -30.60K |
—
|
—
|
0
|
Mar 8
| |||
Form 4
| -8.78% | -2.93K |
$104.44 | -$305,793.88 | 30.41K |
Feb 22 - Feb 23
| |||
Form 4
| +8.49% | 2.61K |
$103.52 | -$117,598.72 | 33.34K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| -2.03% | -636.00 |
$53.65 | -$34,121.40 | 30.73K |
Nov 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +3,090.27% | 29.85K |
$45.97 | -$237,513.62 | 30.82K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xenon Pharmaceuticals Inc. (XENE) Snapshot price: $38.47
Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||